Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2007 1
2011 3
2012 7
2013 6
2014 3
2015 3
2016 4
2017 7
2018 12
2019 11
2020 9
2021 7
2022 3
2023 2
2024 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

70 results

Results by year

Filters applied: . Clear all
Page 1
Budesonide-formoterol reliever therapy versus maintenance budesonide plus terbutaline reliever therapy in adults with mild to moderate asthma (PRACTICAL): a 52-week, open-label, multicentre, superiority, randomised controlled trial.
Hardy J, Baggott C, Fingleton J, Reddel HK, Hancox RJ, Harwood M, Corin A, Sparks J, Hall D, Sabbagh D, Mane S, Vohlidkova A, Martindale J, Williams M, Shirtcliffe P, Holliday M, Weatherall M, Beasley R; PRACTICAL study team. Hardy J, et al. Among authors: fingleton j. Lancet. 2019 Sep 14;394(10202):919-928. doi: 10.1016/S0140-6736(19)31948-8. Epub 2019 Aug 23. Lancet. 2019. PMID: 31451207 Clinical Trial.
Treatable traits of chronic airways disease.
Fingleton J, Hardy J, Beasley R. Fingleton J, et al. Curr Opin Pulm Med. 2018 Jan;24(1):24-31. doi: 10.1097/MCP.0000000000000445. Curr Opin Pulm Med. 2018. PMID: 29049049 Review.
Real-world biologics response and super-response in the International Severe Asthma Registry cohort.
Denton E, Hew M, Peters MJ, Upham JW, Bulathsinhala L, Tran TN, Martin N, Bergeron C, Al-Ahmad M, Altraja A, Larenas-Linnemann D, Murray R, Celis-Preciado CA, Al-Lehebi R, Belhassen M, Bhutani M, Bosnic-Anticevich SZ, Bourdin A, Brusselle GG, Busby J, Canonica GW, Heffler E, Chapman KR, Charriot J, Christoff GC, Chung LP, Cosio BG, Côté A, Costello RW, Cushen B, Fingleton J, Fonseca JA, Gibson PG, Heaney LG, Huang EW, Iwanaga T, Jackson DJ, Koh MS, Lehtimäki L, Máspero J, Mahboub B, Menzies-Gow AN, Mitchell PD, Papadopoulos NG, Papaioannou AI, Perez-de-Llano L, Perng DW, Pfeffer PE, Popov TA, Porsbjerg CM, Rhee CK, Roche N, Sadatsafavi M, Salvi S, Schmid JM, Sheu CC, Sirena C, Torres-Duque CA, Salameh L, Patel PH, Ulrik CS, Wang E, Wechsler ME, Price DB; ISAR LUMINANT Working Group. Denton E, et al. Among authors: fingleton j. Allergy. 2024 Oct;79(10):2700-2716. doi: 10.1111/all.16178. Epub 2024 Jun 22. Allergy. 2024. PMID: 38923444 Free article.
Towards individualised treatment in COPD.
Fingleton J, Weatherall M, Beasley R. Fingleton J, et al. Thorax. 2011 May;66(5):363-4. doi: 10.1136/thx.2010.155564. Epub 2011 Jan 19. Thorax. 2011. PMID: 21248321 No abstract available.
Bronchodilator responsiveness: interpret with caution.
Fingleton J, Weatherall M, Beasley R. Fingleton J, et al. Thorax. 2012 Aug;67(8):667-8. doi: 10.1136/thoraxjnl-2012-201966. Epub 2012 Jun 12. Thorax. 2012. PMID: 22693176 No abstract available.
Severe Asthma Global Evaluation (SAGE): An Electronic Platform for Severe Asthma.
Denton E, Hore-Lacy F, Radhakrishna N, Gilbert A, Tay T, Lee J, Dabscheck E, Harvey ES, Bulathsinhala L, Fingleton J, Price D, Gibson PG, O'Hehir R, Hew M. Denton E, et al. Among authors: fingleton j. J Allergy Clin Immunol Pract. 2019 May-Jun;7(5):1440-1449. doi: 10.1016/j.jaip.2019.02.042. Epub 2019 Apr 4. J Allergy Clin Immunol Pract. 2019. PMID: 30954467 Review.
New Zealand COPD Guidelines: Quick Reference Guide.
Hancox RJ, Jones S, Baggott C, Chen D, Corna N, Davies C, Fingleton J, Hardy J, Hussain S, Poot B, Reid J, Travers J, Turner J, Young R. Hancox RJ, et al. Among authors: fingleton j. N Z Med J. 2021 Feb 19;134(1530):76-110. N Z Med J. 2021. PMID: 33651780
Serum periostin in obstructive airways disease.
Fingleton J, Braithwaite I, Travers J, Bowles D, Strik R, Siebers R, Holweg C, Matthews J, Weatherall M, Beasley R; NZRHS Study Group. Fingleton J, et al. Eur Respir J. 2016 May;47(5):1383-91. doi: 10.1183/13993003.01384-2015. Epub 2016 Feb 25. Eur Respir J. 2016. PMID: 26917610 Free PMC article.
70 results